This is a single-center, open, retrospective clinical study of patients with metastatic/surgically unresectable bone and soft tissue sarcoma undergoing cryoablation of selected tumor lesions. All eligible patients were enrolled. Basic data and treatment methods of these patients were collected, and efficacy and safety were evaluated.
This is a single-center, open, retrospective clinical study of patients with metastatic/surgically unresectable bone and soft tissue sarcoma undergoing cryoablation of selected tumor lesions. Clinical data of eligible patients were scheduled to be retrospectively collected from December 2016 to February 28, 2022. All patients eligible for inclusion. Basic data and treatment methods of these patients were collected, and efficacy and safety were evaluated.
Study Type
OBSERVATIONAL
Enrollment
30
Cryoablation of selected tumor lesions
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Zhengzhou, Henan, China
RECRUITINGSurvival rates
1-year survival rate
Time frame: 12 months after surgery
There was no local recurrence survival rate
The 1-year survival rate without local recurrence
Time frame: 12 months after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.